LXRX 8-K 2026-11-05

LEXICON PHARMACEUTICALS, INC. (LXRX) 8-K dated 2026-11-05 — accession 0001062822-26-000124.

LEXICON PHARMACEUTICALS, INC. (LXRX) is a biotechnology company listed on US.

LEXICON PHARMACEUTICALS, INC. filed a 8-K on 2026-11-05. Accession 0001062822-26-000124.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported LXRX revenue for 2025-12-31 was $49.8M. Net income was -$50.3M. Revenue was up 60.2% from 2024-12-31 to 2025-12-31. LXRX currently screens at market cap $327.2M.

Not investment advice. The LXRX SEC hub lists recent forms. The stock page is the research view.